BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 11295105)

  • 1. An individual patient data meta-analysis of long supported adjuvant chemotherapy with oral carmofur in patients with curatively resected colorectal cancer.
    Sakamoto J; Kodaira S; Hamada C; Ito K; Maehara Y; Takagi H; Sugimachi K; Nakazato H; Ohashi Y;
    Oncol Rep; 2001; 8(3):697-703. PubMed ID: 11295105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An individual patient data meta-analysis of adjuvant therapy with carmofur in patients with curatively resected colon cancer.
    Sakamoto J; Hamada C; Rahman M; Kodaira S; Ito K; Nakazato H; Ohashi Y; Yasutomi M
    Jpn J Clin Oncol; 2005 Sep; 35(9):536-44. PubMed ID: 16155120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant therapy with oral fluoropyrimidines as main chemotherapeutic agents after curative resection for colorectal cancer: individual patient data meta-analysis of randomized trials.
    Sakamoto J; Hamada C; Kodaira S; Nakazato H; Ohashi Y
    Jpn J Clin Oncol; 1999 Feb; 29(2):78-86. PubMed ID: 10089948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postoperative adjuvant chemotherapy with 1-hexylcarbamoyl-5-fluorouracil in patients with colorectal cancer and at a high risk for recurrence.
    Maehara Y; Sugimachi K; Ogawa M; Kakegawa T; Tomita M; Akiyoshi T
    Anticancer Res; 1998; 18(6B):4629-34. PubMed ID: 9891531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized controlled trial of the efficacy of adjuvant immunochemotherapy and adjuvant chemotherapy for colorectal cancer, using different combinations of the intracutaneous streptococcal preparation OK-432 and the oral pyrimidines 1-hexylcarbamoyl-5-fluorouracil and uracil/tegafur.
    Watanabe M; Nishida O; Kunii Y; Kodaira S; Takahashi T; Tominaga T; Hojyo K; Kato T; Niimoto M; Kunitomo K; Isomoto H; Ohashi Y; Yasutomi M
    Int J Clin Oncol; 2004 Apr; 9(2):98-106. PubMed ID: 15108041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Five-year results of a randomized controlled trial of adjuvant chemotherapy for curatively resected colorectal carcinoma. The Colorectal Cancer Chemotherapy Study Group of Japan.
    Jpn J Clin Oncol; 1995 Jun; 25(3):91-103. PubMed ID: 7596054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized controlled trial of 5-fluorouracil (5-FU) infusion combined with 1-hexylcarbamoyl-5-fluorouracil (HCFU) oral administration and HCFU alone as postoperative adjuvant chemotherapy for colorectal cancer.
    Iwagaki H; Tanaka N; Esato K; Kaibara N; Sano K; Dohi K; Nakamura T; Nakasato H; Orita K
    Anticancer Res; 2000; 20(5C):3727-34. PubMed ID: 11268446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The current status of postoperative adjuvant chemotherapy for colorectal cancer].
    Kodaira S
    Gan To Kagaku Ryoho; 1997 Aug; 24(10):1230-8. PubMed ID: 9279341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of oral adjuvant therapy after resection of colorectal cancer: 5-year results from three randomized trials.
    Sakamoto J; Ohashi Y; Hamada C; Buyse M; Burzykowski T; Piedbois P; ;
    J Clin Oncol; 2004 Feb; 22(3):484-92. PubMed ID: 14752071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal duration of oral adjuvant chemotherapy with Carmofur in the colorectal cancer patients: the Kansai Carmofur Study Group trial III.
    Nakamura T; Ohno M; Tabuchi Y; Kamigaki T; Fujii H; Yamagishi H; Kuroda Y;
    Int J Oncol; 2001 Aug; 19(2):291-8. PubMed ID: 11445841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prospective controlled study on the usefulness of Carmofur as a postoperative adjuvant chemotherapy for colorectal cancer].
    Yasutomi M; Takahashi T; Kodaira S; Hojo K; Kato T; Ogawa M; Ichihashi H; Tominaga T; Tamada R; Kunii Y; Kikuchi K
    Gan To Kagaku Ryoho; 1997 Oct; 24(13):1953-60. PubMed ID: 9350242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant therapy of colorectal cancer.
    Kemeny N; Saltz L; Cohen A
    Surg Oncol Clin N Am; 1997 Oct; 6(4):699-722. PubMed ID: 9309089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Importance of 5-fluorouracil dose-intensity in a double randomised trial on adjuvant portal and systemic chemotherapy for Dukes B2 and C colorectal cancer.
    Focan C; Bury J; Beauduin M; Herman ML; Vindevoghel A; Lecomte M; Brohée D; Canon JL; Focan-Henrard D;
    Anticancer Res; 2000; 20(6C):4665-72. PubMed ID: 11205198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized trial of oral 5-fluorouracil versus placebo as adjuvant therapy in colorectal cancer Dukes' B and C: results after 5 years observation time.
    Hafström L; Rudenstam CM; Domellöf L
    Br J Surg; 1985 Feb; 72(2):138-41. PubMed ID: 3882183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An individual patient data meta-analysis of adjuvant therapy with uracil-tegafur (UFT) in patients with curatively resected rectal cancer.
    Sakamoto J; Hamada C; Yoshida S; Kodaira S; Yasutomi M; Kato T; Oba K; Nakazato H; Saji S; Ohashi Y
    Br J Cancer; 2007 Apr; 96(8):1170-7. PubMed ID: 17375049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term results of single course of adjuvant intraportal chemotherapy for colorectal cancer. Swiss Group for Clinical Cancer Research (SAKK).
    Lancet; 1995 Feb; 345(8946):349-53. PubMed ID: 7845115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prospective adjuvant chemotherapy, with mitomycin C plus long-term carmofur in colorectal cancer].
    Terabe K; Yamauchi M; Watanabe T; Ichihashi H; Takagi H; Imaizumi M; Kondo T
    Gan No Rinsho; 1986 Mar; 32(3):261-7. PubMed ID: 3086597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Should Dukes' B patients receive adjuvant therapy? A statistical perspective.
    Buyse M; Piedbois P
    Semin Oncol; 2001 Feb; 28(1 Suppl 1):20-4. PubMed ID: 11273585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimum duration of oral adjuvant chemotherapy of HCFU for colorectal cancer; review of 5-year follow-up.
    Ito K; Kato T; Koike A; Miura K; Yamaguchi A; Sakou T; Takagi H
    Anticancer Res; 2000; 20(6C):4681-6. PubMed ID: 11205200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized clinical trial of adjuvant radiotherapy and 5-fluorouracil infusion in colorectal cancer (AXIS).
    James RD; Donaldson D; Gray R; Northover JM; Stenning SP; Taylor I;
    Br J Surg; 2003 Oct; 90(10):1200-12. PubMed ID: 14515287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.